Understanding the Role of Brain Immune Cells in Protection Against Alzheimer’s
Principal Investigator
Ghazaleh Eskandari-Sedighi, PhD
University of California, Irvine
Irvine, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
July 01, 2025 - June 30, 2027
Grant ID
A2025007F
Goals
Our goal is to learn about naturally available ways the brain fights against Alzheimer’s disease to help the development of more efficient therapeutics.
Summary
Understanding how Alzheimer’s disease (AD) is formed is challenging due to the complex, multifaceted nature of the disease. It is known now that the heritability of AD is over 60%. So, understanding the disease mechanism can be achieved by exploring these hereditary elements in patients vs. healthy individuals. Of note, some rare hereditary factors turn out to be protective and can provide protection against AD. Taking advantage of novel, multi-faceted stem cell models, we will study ApoE3 Christchurch as one of these rare, resilient factors, with a specific focus on brain-resident immune cells.
Unique and Innovative
Taking advantage of human stem cell techniques, we use a novel state-of-the-art model that enables studying biology of human brain resident immune cells. Moreover, we have recently made advancements in enhancing our model to better recapitulate all aspects of Alzheimer’s disease. This research may help explain why some people with high levels of Alzheimer’s disease toxic proteins stay healthier than others.
Foreseeable Benefits
Our proposed experiments will help reveal mechanisms of protective paths that the brain immune cells take. This information will provide valuable new insight that could inform the development of promising new therapeutic approaches.
Related Grants
Alzheimer's Disease Research
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco
Alzheimer's Disease Research
Developing a Noninvasive Gene Therapy for Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Dominika Pilat, PhD
Current Organization
Massachusetts General Hospital
Developing a Noninvasive Gene Therapy for Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Dominika Pilat, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Exploring How Signals from the Body Influence Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Haoyue Zhou, PhD
Current Organization
Gladstone Institutes
Exploring How Signals from the Body Influence Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Haoyue Zhou, PhD
Current Organization
Gladstone Institutes